Alexander E, Weingarten S, Mohsenifar Z
Department of Medicine, Cedars-Sinai Medical Center, UCLA School of Medicine, USA.
Chest. 1996 Aug;110(2):430-2. doi: 10.1378/chest.110.2.430.
There is widespread interest in the evaluation of clinical strategies that safely reduce health-care costs. Elimination of inappropriate chest physiotherapy may represent one of those strategies.
An academic community hospital.
One-hundred one patients receiving chest physiotherapy were prospectively randomized to continue their chest physiotherapy or to inform their physicians that the order for the chest physiotherapy may have been inappropriate.
Patients who were randomized to have their chest physiotherapy discontinued received 45% fewer chest physiotherapy treatments than control patients (p < 0.01). There was no increase in the mortality rate or length of hospital stay associated with the reduction in chest physiotherapy in carefully selected patients. The estimated cost savings would be $319,000, which is 50 times greater than the cost associated with the intervention.
Chest physiotherapy is frequently provided to patients for inappropriate indications. Reducing chest physiotherapy for these patients may significantly reduce respiratory therapy costs without increasing length of stay or mortality rates.
对于安全降低医疗成本的临床策略评估存在广泛关注。消除不适当的胸部物理治疗可能是其中一种策略。
一家学术社区医院。
前瞻性地将101名接受胸部物理治疗的患者随机分为继续接受胸部物理治疗组或告知其医生胸部物理治疗医嘱可能不适当组。
被随机分配停止胸部物理治疗的患者接受的胸部物理治疗次数比对照组患者少45%(p<0.01)。在精心挑选的患者中,胸部物理治疗减少并未导致死亡率增加或住院时间延长。估计节省成本319,000美元,这比干预相关成本高50倍。
胸部物理治疗经常被用于不适当的适应症患者。减少这些患者的胸部物理治疗可能显著降低呼吸治疗成本,而不增加住院时间或死亡率。